Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000733065 | SCV000861084 | pathogenic | not provided | 2018-05-08 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990641 | SCV001141658 | pathogenic | Duchenne muscular dystrophy | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000990641 | SCV002144655 | pathogenic | Duchenne muscular dystrophy | 2024-07-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu1900Ilefs*6) in the DMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DMD are known to be pathogenic (PMID: 16770791, 25007885). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Duchenne muscular dystrophy (PMID: 19959795). ClinVar contains an entry for this variant (Variation ID: 597052). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Laboratory of Medical Genetics, |
RCV000990641 | SCV002769613 | pathogenic | Duchenne muscular dystrophy | 2022-12-16 | criteria provided, single submitter | clinical testing | PVS1, PM2, PP5 |
Revvity Omics, |
RCV000733065 | SCV003827592 | pathogenic | not provided | 2022-05-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000733065 | SCV005888939 | pathogenic | not provided | 2024-09-13 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34802424, 34679607, 36082559, 19959795, 16770791) |
Natera, |
RCV001830629 | SCV002093470 | pathogenic | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2021-03-24 | no assertion criteria provided | clinical testing |